This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jan;14(1):2-3.

doi: 10.1038/nrclinonc.2016.198. Epub 2016 Nov 29.

Targeted therapies: Widening the treatment NET

Lisa Hutchinson

PMID: 27898066
DOI: 10.1038/nrclinonc.2016.198

Comment

Targeted therapies: Widening the treatment NET

Lisa Hutchinson. Nat Rev Clin Oncol. 2017 Jan.

. 2017 Jan;14(1):2-3.

doi: 10.1038/nrclinonc.2016.198. Epub 2016 Nov 29.

Author

Lisa Hutchinson

PMID: 27898066
DOI: 10.1038/nrclinonc.2016.198

No abstract available

PubMed Disclaimer

Comment on

Sunitinib in pancreatic neuroendocrine tumors: updated progression-free survival and final overall survival from a phase III randomized study.
Faivre S, Niccoli P, Castellano D, Valle JW, Hammel P, Raoul JL, Vinik A, Van Cutsem E, Bang YJ, Lee SH, Borbath I, Lombard-Bohas C, Metrakos P, Smith D, Chen JS, Ruszniewski P, Seitz JF, Patyna S, Lu DR, Ishak KJ, Raymond E. Faivre S, et al. Ann Oncol. 2017 Feb 1;28(2):339-343. doi: 10.1093/annonc/mdw561. Ann Oncol. 2017. PMID: 27836885 Clinical Trial.

References

1. Ann Oncol. 2016 Nov 10;:null - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information